loading
前日終値:
$0.7877
開ける:
$0.78
24時間の取引高:
15,849
Relative Volume:
0.01
時価総額:
$3.01M
収益:
-
当期純損益:
$-16.08M
株価収益率:
-0.3801
EPS:
-2.21
ネットキャッシュフロー:
$-11.54M
1週間 パフォーマンス:
-6.67%
1か月 パフォーマンス:
-21.50%
6か月 パフォーマンス:
-58.00%
1年 パフォーマンス:
-91.60%
1日の値動き範囲:
Value
$0.78
$0.845
1週間の範囲:
Value
$0.61
$0.97
52週間の値動き範囲:
Value
$0.61
$12.37

Bio Path Holdings Inc Stock (BPTH) Company Profile

Name
名前
Bio Path Holdings Inc
Name
セクター
Healthcare (1195)
Name
電話
(832) 742-1357
Name
住所
4710 BELLAIRE BOULEVARD, BELLAIRE, TX
Name
職員
10
Name
Twitter
Name
次回の収益日
2024-12-15
Name
最新のSEC提出書
Name
BPTH's Discussions on Twitter

BPTH を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
BPTH 0.80 3.01M 0 -16.08M -11.54M -2.21
VRTX 449.69 115.43B 10.63B -479.80M -1.35B 13.33
REGN 748.75 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 588.46 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 247.89 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 106.23 24.89B 3.30B -501.07M 1.03B 11.54

Bio Path Holdings Inc Stock (BPTH) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2021-03-11 開始されました ROTH Capital Buy
2017-11-13 繰り返されました H.C. Wainwright Buy
2016-08-10 繰り返されました Maxim Group Buy
2016-04-18 開始されました Rodman & Renshaw Buy
2014-06-02 再開されました Maxim Group Buy
2014-05-09 開始されました Maxim Group Buy
すべてを表示

Bio Path Holdings Inc (BPTH) 最新ニュース

pulisher
Nov 20, 2024

Bio-Path Holdings Inc (BPTH) Q3 2024 Earnings Call Highlights: S - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

Bio-Path Holdings Inc (BPTH) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial ... - Yahoo Finance

Nov 20, 2024
pulisher
Nov 20, 2024

Bio-Path (BPTH) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Zacks Investment Research

Nov 20, 2024
pulisher
Nov 20, 2024

All You Need to Know About Bio-Path (BPTH) Rating Upgrade to Buy - Yahoo Finance

Nov 20, 2024
pulisher
Nov 20, 2024

Bio-Path Holdings Expands DNAbilize® Technology Applications - MSN

Nov 20, 2024
pulisher
Nov 18, 2024

Bio-Path stock plunges to 52-week low, hits $0.79 By Investing.com - Investing.com Canada

Nov 18, 2024
pulisher
Nov 18, 2024

Bio-Path stock plunges to 52-week low, hits $0.79 - Investing.com

Nov 18, 2024
pulisher
Nov 18, 2024

Biotricity, Inc. (NASDAQ:BTCY) Q2 2025 Earnings Call Transcript - Insider Monkey

Nov 18, 2024
pulisher
Nov 17, 2024

BIO-key International Reports Financial Results for Third Quarter 2024 - Defense World

Nov 17, 2024
pulisher
Nov 17, 2024

First National Corporation (NASDAQ:FXNC) Declares Quarterly Cash Dividend of $0.155 per Share - Defense World

Nov 17, 2024
pulisher
Nov 17, 2024

Arbutus Biopharma Announces Positive Data from Clinical Trials at AASLD – The Liver Meeting® 2024 - Defense World

Nov 17, 2024
pulisher
Nov 17, 2024

Empire Petroleum Corporation Report Q3 2024 Financial and Operating Results - Defense World

Nov 17, 2024
pulisher
Nov 17, 2024

Bio-Path Holdings Reports Third Quarter 2024 Financial Results and Expansion into Obesity Program - Defense World

Nov 17, 2024
pulisher
Nov 16, 2024

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 16, 2024
pulisher
Nov 16, 2024

Bio-Path: Q3 Earnings Snapshot - New Haven Register

Nov 16, 2024
pulisher
Nov 15, 2024

Earnings call: Bio-Path Holdings reports Q3 2024 financials, pipeline updates - Investing.com Canada

Nov 15, 2024
pulisher
Nov 15, 2024

Bio-Path Holdings Reports Third Quarter 2024 Financial Results - citybiz

Nov 15, 2024
pulisher
Nov 15, 2024

Bio-Path Holdings Expands to Obesity Market, Reports $2.1M Q3 Loss, Raises $4M | BPTH Stock News - StockTitan

Nov 15, 2024
pulisher
Nov 15, 2024

Bio-Path Holdings Inc (BPTH) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 14, 2024

Some Numbers at Parker Drilling that Make Your Stock Look Good - AOL

Nov 14, 2024
pulisher
Nov 13, 2024

Bio Path Holdings Inc expected to post a loss of $1.02 a shareEarnings Preview - XM

Nov 13, 2024
pulisher
Nov 13, 2024

Bio-Path (BPTH) Scheduled to Post Quarterly Earnings on Friday - Defense World

Nov 13, 2024
pulisher
Nov 11, 2024

Pre-market Movers: REVB, CDIO, SMLR, DWTX... - RTTNews

Nov 11, 2024
pulisher
Nov 08, 2024

Bio-Path Holdings to Announce Third Quarter 2024 Financial Results on November 15, 2024 - StockTitan

Nov 08, 2024
pulisher
Nov 08, 2024

Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO®/DARZALEX® (daratumumab) as subcutaneous monotherapy for high-risk smouldering multiple myeloma - The Manila Times

Nov 08, 2024
pulisher
Nov 08, 2024

Bio-Path (NASDAQ:BPTH) Now Covered by Analysts at StockNews.com - Defense World

Nov 08, 2024
pulisher
Nov 06, 2024

BPTH stock touches 52-week low at $0.84 amid sharp annual decline - Investing.com UK

Nov 06, 2024
pulisher
Oct 31, 2024

T-cell Malignancies Clinical Trial Pipeline Insights Featuring 70+ Companies | DelveInsight - The Malaysian Reserve

Oct 31, 2024
pulisher
Oct 29, 2024

Antisense Oligonucleotide Therapeutics Market Poised for Significant Growth, Projected to Reach $64.64 Bill... - WhaTech

Oct 29, 2024
pulisher
Oct 27, 2024

RNA Interference Therapy Competitive Landscape Report 2024 (Updated) - openPR

Oct 27, 2024
pulisher
Oct 23, 2024

Bio-Path (NASDAQ:BPTH) Earns Sell Rating from Analysts at StockNews.com - Defense World

Oct 23, 2024
pulisher
Oct 21, 2024

RNA-based Therapeutics Market Latest Trends Analysis Report 2024 - InsightAce Analytic

Oct 21, 2024
pulisher
Oct 18, 2024

siRNA Therapeutics Market Set for Explosive Growth, Projected to Reach $48.46 Billion by 2031 - WhaTech

Oct 18, 2024
pulisher
Oct 16, 2024

80+ Pharma Companies Unite to Shape the Future of RNA-Based Therapeutics | DelveInsight - 新浪香港

Oct 16, 2024
pulisher
Oct 15, 2024

siRNA Therapeutics Market Set for Explosive Growth, Expected to Hit $48.46 Billion by 2031 As Revealed In N... - WhaTech

Oct 15, 2024
pulisher
Oct 15, 2024

Thyroid Cancer Drug Market to Exhibit a Remarkable CAGR of 17.2% - openPR

Oct 15, 2024
pulisher
Oct 14, 2024

Chronic Myeloid Leukemia (CML) Treatment Market Report Analysis, Research Studies |Novartis AG, Bristol-Myers Squibb, Te – IndiaPolitics.com - IndiaPolitics.com

Oct 14, 2024
pulisher
Oct 14, 2024

Antisense Oligonucleotide (ASO) Therapeutics Market Size, Share, and Future Growth Analysis (2024-2032) - News in Assen

Oct 14, 2024
pulisher
Oct 14, 2024

Antisense and RNAi Therapeutics Market Growth, Share, and Industry Forecast (2024-2032) - News in Assen

Oct 14, 2024
pulisher
Oct 14, 2024

Wells Fargo & Company (WFC-N) QuotePress Release - The Globe and Mail

Oct 14, 2024
pulisher
Oct 11, 2024

New World Solutions (CSE: NEWS) (OTC: REGRF) Appoints Capital Markets Veteran Martin Tremblay to Board of Directors - Wall Street Reporter

Oct 11, 2024
pulisher
Oct 11, 2024

Analytical Overview: Bio-Path Holdings Inc (BPTH)’s Ratios Tell a Financial Story - The Dwinnex

Oct 11, 2024
pulisher
Oct 11, 2024

Bio-Path Holdings Raises $4M Through Private Placement - TipRanks

Oct 11, 2024
pulisher
Oct 11, 2024

Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - The Manila Times

Oct 11, 2024
pulisher
Oct 10, 2024

Why this investor is skeptical about Tesla's robotaxi event - Yahoo Finance UK

Oct 10, 2024
pulisher
Oct 10, 2024

Portfolio manager sees 'no landing' for US economy - Yahoo Finance UK

Oct 10, 2024
pulisher
Oct 10, 2024

Russia to raise foreign company 'exit tax' to 35% from 15%, business daily reports - Yahoo Finance UK

Oct 10, 2024

Bio Path Holdings Inc (BPTH) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):